首页> 外文期刊>BMC Pediatrics >Lung function in very low birth weight infants after pharmacological and surgical treatment of patent ductus arteriosus - a retrospective analysis
【24h】

Lung function in very low birth weight infants after pharmacological and surgical treatment of patent ductus arteriosus - a retrospective analysis

机译:动脉导管未闭的药物和手术治疗后超低体重婴儿的肺功能-回顾性分析

获取原文
           

摘要

Background The indications and strategies for treatment of patent ductus arteriosus (PDA) are controversial, and the safety and long-term benefits of surgical PDA closure remain uncertain. The aim of this study was to compare the lung function of very low birth weight (VLBW) infants after successful PDA treatment with a cyclooxygenase inhibitor or secondary surgical ligation. Methods A total of 114 VLBW infants (birth weight?6 multiple breath washout, forced expiratory flow (V’maxFRC) by the rapid thoracoabdominal compression technique, exhaled NO (FeNO), and arterialized capillary blood gas analysis. Results On the day of the LFT, the 2 groups had similar postconceptional age and body weight. However, the PDA ligation group was more immature at birth ( p FRC ( p =?0.006), increased airway resistance (Raw) ( p aw. Conclusion PDA ligation after failed pharmacological treatment is associated with impaired lung function as compared to successful pharmacological closure in infants at a postmenstrual age of 48?weeks. However, only Raw was independently affected by PDA ligation, while all other differences were merely explained by patient characteristics.
机译:背景技术治疗动脉导管未闭(PDA)的适应症和策略存在争议,并且外科手术PDA闭合的安全性和长期获益仍不确定。这项研究的目的是比较用环氧合酶抑制剂或二次手术结扎成功进行PDA治疗后的极低出生体重(VLBW)婴儿的肺功能。方法对114例VLBW婴儿(出生体重≥6多次呼吸冲刷,快速胸腹压迫呼气(V'max FRC ),呼出NO(FeNO),结果在LFT当天,两组的受孕年龄和体重相似,但是PDA结扎组出生时更不成熟(p FRC (p =?0.006),结论与48岁婴儿经药理成功关闭后相比,药物治疗失败后的PDA结扎与肺功能受损有关,结论是PDA结扎是与肺功能受损有关。但是,只有Raw受到PDA结扎的独立影响,而所有其他差异仅由患者特征来解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号